tirzepatide idiopathic intracranial hypertension Efficacy of Dual GIP/GLP‐1 Receptor Agonist in Patients With Hypertension. A Real‐World Propensity Score‐Matched Study - Azzam - 2025 - Endocrinology, Diabetes & Metabolism Bariatric Surgery Promising in Idiopathic

Neurological Health With neuroprotective properties, BPC-157 is shown in animal models to reduce damage due to central nervous system injuries and strokes

CAS No: 2061897-68-3 Molecular Formula: C34H38N4O5 Molecular Weight: 582.7 CAT No: ALL-S08802 Keywords: SMILES string - O=C(NC(C)(C)C(O)=O)[C@@H

Semaglutide: first global approval

Pharmacist Zeinab Ardeshir from PillSorted explores the complexities of menopausal weight changes and how GLP-1 injections might offer a pathway to better health and well-being

Located in the heart of Charlotte, NC, our clinic offers a sophisticated environment for those seeking to move beyond quick fixes and address the root causes of their health concerns

(All compounded medication purchases are considered part of the GLP-1 ID program.) *Based on Ivims published study, Ivim patients following the Ivim Protocol lost an average of 46% more weight over 68 weeks when compared to another published clinical GLP-1 trial that included a daily 500-calorie deficit, 150 minutes of weekly exercise, and in-person counseling every four weeks